Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)
Financial Results:
Cipla Ltd reported Revenues for Q2FY24 of ₹6,678.00 Crores up from ₹5,829.00 Crore year on year, a rise of 14.57%.
Total Expenses for Q2FY24 of ₹5,260.00 Crores up from ₹4,851.00 Crores year on year, a rise of 8.43%.
Consolidated Net Profit of ₹1,155.00 Crores up 44.92% from ₹797.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹14.01, up 43.25% from ₹9.78 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.